Until now resurfacing has been unavailable to female patients due to poor outcomes with metal implants. BUT by May 2025 we expect to have access to the new ceramic resurfacing implants. Extensively trialled internationally, results out to 5 years suggest that outcomes are excellent in both female and male patients equally. Potentially a gamechanger! My practice in Bristol will be one of only 6 centres nationally to launch the delivery of the new ReCerf implant due to extensive experience using the metal resurfacing device.

The first randomised controlled trial looking at Surgery versus Conservative treatment for Femoroacetabular Impingement. Bristol was a contributing centre. Evidence supports the improved outcomes of surgical intervention. Read it for yourself at TheLancet.com